[
  {
    "ts": "2026-01-29T08:30:00+00:00",
    "headline": "ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing",
    "summary": "ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, announced today that Reman McDonagh, PhD, has joined the Company as Vice President, Global Marketing. McDonagh's appointment further strengthens ViCentra's leadership team as the company scales commercial execution across Europe and advances preparations for its next-generation Kaleido system, including EU and U.S. launches.",
    "url": "https://finance.yahoo.com/news/vicentra-appoints-diabetes-commercialization-leader-083000010.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "a70a7511-5567-3c7b-87ab-22a58d61ba70",
      "content": {
        "id": "a70a7511-5567-3c7b-87ab-22a58d61ba70",
        "contentType": "STORY",
        "title": "ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing",
        "description": "",
        "summary": "ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, announced today that Reman McDonagh, PhD, has joined the Company as Vice President, Global Marketing. McDonagh's appointment further strengthens ViCentra's leadership team as the company scales commercial execution across Europe and advances preparations for its next-generation Kaleido system, including EU and U.S. launches.",
        "pubDate": "2026-01-29T08:30:00Z",
        "displayTime": "2026-01-29T08:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/7c2ea2bd7b60759d244f9e9949957c02",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MExD5dMg0sFFeleK_O6klg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/7c2ea2bd7b60759d244f9e9949957c02.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xP13P6.FJE40YDwlLfUAyg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7c2ea2bd7b60759d244f9e9949957c02.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vicentra-appoints-diabetes-commercialization-leader-083000010.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vicentra-appoints-diabetes-commercialization-leader-083000010.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "PODD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]